Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pediatric Allergic Contact Dermatitis Registry patch testing results from 2016 to 2022: A retrospective study of age-related differences.
Young K, Collis RW, Sheinbein D, Shope C, Suresh T, Tam I, Snyder A, Cotton C, Hunt R, Goldenberg A, Goldminz A, Lugo-Somolinos A, Grisham E, Martin KL, Sandhu M, Eichenfield DZ, Sprague J, Kleinman EP, Sum K, Chen JK, Teng J, Aquino MR, Plante J, Franca K, Onate A, Udrizar P, Liszewski W, Yu J. Young K, et al. Among authors: udrizar p. J Am Acad Dermatol. 2023 May;88(5):1218-1220. doi: 10.1016/j.jaad.2023.01.016. Epub 2023 Jan 20. J Am Acad Dermatol. 2023. PMID: 36682723 No abstract available.
Retrospective review of pediatric patch testing results in skin of color.
Young K, Collis RW, Sheinbein D, Shope C, Suresh T, Tam I, Snyder A, Cotton C, Hunt R, Goldenberg A, Goldminz A, Lugo-Somolinos A, Grisham E, Martin KL, Sandhu M, Eichenfield D, Sprague J, Kleinman E, Sum K, Chen JK, Teng J, Aquino MR, Plante J, Franca K, Onate A, Udrizar P, Liszewski W, Yu J. Young K, et al. Among authors: udrizar p. J Am Acad Dermatol. 2023 Apr;88(4):953-954. doi: 10.1016/j.jaad.2022.11.031. Epub 2022 Nov 24. J Am Acad Dermatol. 2023. PMID: 36427663 No abstract available.
Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial.
Okata-Karigane U, Pathmarajah P, Gorell ES, Sum K, Yekrang K, Phung M, Barriga M, Udrizar P, Bailey I, Li S, Lu Y, Tang JY, Chiou AS. Okata-Karigane U, et al. Among authors: udrizar p. J Eur Acad Dermatol Venereol. 2024 Jul 1. doi: 10.1111/jdv.20189. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38949042 No abstract available.